Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Defining a new molecular basis of systemic lupus erythematosus through transcriptional profiling.

Gaffney PM, Moser KL, Baechler EC.

Expert Rev Clin Immunol. 2007 Nov;3(6):913-23. doi: 10.1586/1744666X.3.6.913.

PMID:
20477140
[PubMed]
2.

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B.

Arthritis Rheum. 2009 Jun;60(6):1785-96. doi: 10.1002/art.24557.

PMID:
19479852
[PubMed - indexed for MEDLINE]
Free Article
3.

Gene expression studies in systemic lupus erythematosus.

Mandel M, Achiron A.

Lupus. 2006;15(7):451-6. Review.

PMID:
16898181
[PubMed - indexed for MEDLINE]
4.

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V.

J Exp Med. 2003 Mar 17;197(6):711-23.

PMID:
12642603
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1.

Ye S, Pang H, Gu YY, Hua J, Chen XG, Bao CD, Wang Y, Zhang W, Qian J, Tsao BP, Hahn BH, Chen SL, Rao ZH, Shen N.

Rheumatology (Oxford). 2003 Oct;42(10):1155-63. Epub 2003 May 30.

PMID:
12777642
[PubMed - indexed for MEDLINE]
Free Article
6.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
7.

The emerging role of interferon in human systemic lupus erythematosus.

Baechler EC, Gregersen PK, Behrens TW.

Curr Opin Immunol. 2004 Dec;16(6):801-7. Review.

PMID:
15511676
[PubMed - indexed for MEDLINE]
8.

Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.

Biesen R, Demir C, Barkhudarova F, Grün JR, Steinbrich-Zöllner M, Backhaus M, Häupl T, Rudwaleit M, Riemekasten G, Radbruch A, Hiepe F, Burmester GR, Grützkau A.

Arthritis Rheum. 2008 Apr;58(4):1136-45. doi: 10.1002/art.23404.

PMID:
18383365
[PubMed - indexed for MEDLINE]
Free Article
9.

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.

Arthritis Rheum. 2005 May;52(5):1491-503.

PMID:
15880830
[PubMed - indexed for MEDLINE]
Free Article
10.

Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.

Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA.

Ann Rheum Dis. 2008 Aug;67(8):1069-75. Epub 2007 Dec 6.

PMID:
18063674
[PubMed - indexed for MEDLINE]
11.

Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?

Al Attia HM.

Int J Dermatol. 2006 Apr;45(4):366-9.

PMID:
16650159
[PubMed - indexed for MEDLINE]
12.

Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus.

Qing X, Putterman C.

Autoimmun Rev. 2004 Nov;3(7-8):505-9. Review.

PMID:
15546798
[PubMed - indexed for MEDLINE]
13.

Type I interferon in systemic lupus erythematosus.

Crow MK.

Curr Top Microbiol Immunol. 2007;316:359-86. Review.

PMID:
17969456
[PubMed - indexed for MEDLINE]
14.

Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.

Lipka K, Tebbe B, Finckh U, Rolfs A.

Clin Exp Dermatol. 1996 Jan;21(1):38-42.

PMID:
8689767
[PubMed - indexed for MEDLINE]
15.

Interferon-alpha in systemic lupus erythematosus.

Crow MK, Kirou KA.

Curr Opin Rheumatol. 2004 Sep;16(5):541-7. Review.

PMID:
15314491
[PubMed - indexed for MEDLINE]
16.

MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N.

Arthritis Rheum. 2009 Apr;60(4):1065-75. doi: 10.1002/art.24436.

PMID:
19333922
[PubMed - indexed for MEDLINE]
Free Article
17.

Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients.

Ishii T, Onda H, Tanigawa A, Ohshima S, Fujiwara H, Mima T, Katada Y, Deguchi H, Suemura M, Miyake T, Miyatake K, Kawase I, Zhao H, Tomiyama Y, Saeki Y, Nojima H.

DNA Res. 2005;12(6):429-39. Epub 2006 Feb 23.

PMID:
16769699
[PubMed - indexed for MEDLINE]
Free Article
18.

Dissecting the molecular mechanisms of TCR zeta chain downregulation and T cell signaling abnormalities in human systemic lupus erythematosus.

Nambiar MP, Juang YT, Krishnan S, Tsokos GC.

Int Rev Immunol. 2004 May-Aug;23(3-4):245-63. Review.

PMID:
15204087
[PubMed - indexed for MEDLINE]
19.

Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.

Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Park SH, Kim HY, Cho YG.

Arthritis Res Ther. 2008;10(2):R29. doi: 10.1186/ar2382. Epub 2008 Mar 6.

PMID:
18321389
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus.

Landolt-Marticorena C, Bonventi G, Lubovich A, Ferguson C, Unnithan T, Su J, Gladman DD, Urowitz M, Fortin PR, Wither J.

Ann Rheum Dis. 2009 Sep;68(9):1440-6. doi: 10.1136/ard.2008.093146. Epub 2008 Sep 4.

PMID:
18772188
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk